{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:20:35Z","timestamp":1788315635885,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.14283\/jpad.2022.56","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T06:54:31Z","timestamp":1654152871000},"page":"617-624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Amyloid-Related Imaging Abnormalities and Other MRI Findings in a Cognitively Unimpaired Population With and Without Cerebral Amyloid"],"prefix":"10.1016","volume":"9","author":[{"given":"Roy","family":"Yaari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.C.","family":"Holdridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Donohue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kantarci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"C.R.","family":"Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Zuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.R.","family":"Sims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.S.","family":"Aisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Sperling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.14283\/jpad.2022.56_bib1","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1212\/WNL.0b013e3181c67808","article-title":"A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease","volume":"73","author":"Salloway","year":"2009","journal-title":"Neurology"},{"issue":"4","key":"10.14283\/jpad.2022.56_bib2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","article-title":"Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.14283\/jpad.2022.56_bib3","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3233\/JAD-180675","article-title":"Clinical Evaluation of Amyloid-Related Imaging Abnormalities in Bapineuzumab Phase III Studies","volume":"66","author":"Brashear","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"10.14283\/jpad.2022.56_bib4","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jalz.2011.05.2353","article-title":"Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab","volume":"7","author":"Carlson","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"19","key":"10.14283\/jpad.2022.56_bib5","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1212\/WNL.0000000000000957","article-title":"Spontaneous amyloid-related imaging abnormalities in a cognitively normal adult","volume":"83","author":"Raman","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"10.14283\/jpad.2022.56_bib6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(12)70015-7","article-title":"Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis","volume":"11","author":"Sperling","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.14283\/jpad.2022.56_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.dadm.2016.02.004","article-title":"Amyloid-related imaging abnormalities from trials of solanezumab for Alzheimer's disease","volume":"2","author":"Carlson","year":"2016","journal-title":"Alzheimers Dement (Amst)"},{"issue":"24","key":"10.14283\/jpad.2022.56_bib8","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1212\/WNL.0b013e3181e396ea","article-title":"Incidence of cerebral microbleeds: a longitudinal study in a memory clinic population","volume":"74","author":"Goos","year":"2010","journal-title":"Neurology"},{"issue":"3","key":"10.14283\/jpad.2022.56_bib9","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1212\/WNL.0000000000006780","article-title":"Cerebral microbleeds: Prevalence and relationship to amyloid burden","volume":"92","author":"Graff-Radford","year":"2019","journal-title":"Neurology"},{"issue":"5","key":"10.14283\/jpad.2022.56_bib10","first-page":"S116","article-title":"Focal hemosiderin deposits and beta-amyloid load in the ADNI cohort","volume":"9","author":"Kantarci","year":"2013","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.14283\/jpad.2022.56_bib11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3233\/JAD-160216","article-title":"Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease Patients","volume":"57","author":"Ketter","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"10.14283\/jpad.2022.56_bib12","first-page":"S103","article-title":"Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study","volume":"41","author":"Poels","year":"2010","journal-title":"Stroke"},{"issue":"2","key":"10.14283\/jpad.2022.56_bib13","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1212\/WNL.0000000000008735","article-title":"Cerebral microbleed incidence, relationship to amyloid burden: The Mayo Clinic Study of Aging","volume":"94","author":"Graff-Radford","year":"2020","journal-title":"Neurology"},{"issue":"1","key":"10.14283\/jpad.2022.56_bib14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1212\/WNL.0b013e318221ad36","article-title":"Cerebral microhemorrhage and brain beta-amyloid in aging and Alzheimer disease","volume":"77","author":"Yates","year":"2011","journal-title":"Neurology"},{"issue":"6","key":"10.14283\/jpad.2022.56_bib15","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jamaneurol.2020.0387","article-title":"Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals","volume":"77","author":"Sperling","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.14283\/jpad.2022.56_bib16","series-title":"Akaike Information Criterion Statistics","first-page":"316","author":"Sakamoto","year":"1986"},{"key":"10.14283\/jpad.2022.56_bib17","doi-asserted-by":"crossref","unstructured":"Kosmidis I, Schumacher D. detectseparation: Detect and Check for Separation and Infinite Maximum Likelihood Estimates. R package version 0.1. 2020.","DOI":"10.32614\/CRAN.package.detectseparation"},{"issue":"1","key":"10.14283\/jpad.2022.56_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.2517-6161.1989.tb01752.x","article-title":"Partial separation in logistic discrimination","volume":"51","author":"Lesaffre","year":"1989","journal-title":"Journal of the Royal Statistical Society: Series B (Methodological)"},{"issue":"4","key":"10.14283\/jpad.2022.56_bib19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1474-4422(18)30029-2","article-title":"Cognitive and neuroimaging features and brain beta-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study","volume":"17","author":"Dubois","year":"2018","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.14283\/jpad.2022.56_bib20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1474-4422(17)30077-7","article-title":"Age-specific and sex-specific prevalence of cerebral beta-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50\u201395 years: a cross-sectional study","volume":"16","author":"Jack","year":"2017","journal-title":"Lancet Neurol"},{"issue":"19","key":"10.14283\/jpad.2022.56_bib21","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis","volume":"313","author":"Jansen","year":"2015","journal-title":"JAMA"},{"issue":"3","key":"10.14283\/jpad.2022.56_bib22","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/STROKEAHA.110.607184","article-title":"Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study","volume":"42","author":"Poels","year":"2011","journal-title":"Stroke"},{"issue":"7","key":"10.14283\/jpad.2022.56_bib23","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1161\/STROKEAHA.118.021789","article-title":"Antiplatelet Therapy, Cerebral Microbleeds, and Intracerebral Hemorrhage: A Meta-Analysis","volume":"49","author":"Qiu","year":"2018","journal-title":"Stroke"},{"issue":"12","key":"10.14283\/jpad.2022.56_bib24","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1161\/STROKEAHA.117.018974","article-title":"Prevalence and Natural History of Superficial Siderosis: A Population-Based Study","volume":"48","author":"Pichler","year":"2017","journal-title":"Stroke"},{"issue":"3","key":"10.14283\/jpad.2022.56_bib25","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1212\/WNL.0b013e3181ae7c5e","article-title":"Superficial siderosis in the general population","volume":"73","author":"Vernooij","year":"2009","journal-title":"Neurology"},{"issue":"8","key":"10.14283\/jpad.2022.56_bib26","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/jnnp-2012-303898","article-title":"Genetics of cerebral amyloid angiopathy: systematic review and meta-analysis","volume":"84","author":"Rannikmae","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.14283\/jpad.2022.56_bib27","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/CIRCULATIONAHA.115.016261","article-title":"Cerebral Microbleeds Are Associated With an Increased Risk of Stroke: The Rotterdam Study","volume":"132","author":"Akoudad","year":"2015","journal-title":"Circulation"},{"issue":"7","key":"10.14283\/jpad.2022.56_bib28","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1161\/STROKEAHA.110.601922","article-title":"Microbleeds are associated with subsequent hemorrhagic and ischemic stroke in healthy elderly individuals","volume":"42","author":"Bokura","year":"2011","journal-title":"Stroke"},{"issue":"8","key":"10.14283\/jpad.2022.56_bib29","doi-asserted-by":"crossref","first-page":"e71467","DOI":"10.1371\/journal.pone.0071467","article-title":"Incidental findings on brain MR imaging in older community-dwelling subjects are common but serious medical consequences are rare: a cohort study","volume":"8","author":"Sandeman","year":"2013","journal-title":"PLoS One"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S227458072400270X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S227458072400270X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T21:11:07Z","timestamp":1737321067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S227458072400270X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S227458072400270X"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2022.56","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amyloid-Related Imaging Abnormalities and Other MRI Findings in a Cognitively Unimpaired Population With and Without Cerebral Amyloid","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2022.56","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}